
Long Life Pharmaceuticals Private Limited
About Long Life Pharmaceuticals Private Limited
Data last updated:
Long Life Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the diversified operations segment of the manufacturing sector. It was incorporated on 04 March 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U36990DL2016PTC292179. Its GSTIN is 09AADCL0261G1ZR (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Dev Muni Upadhyay (Managing Director) and Vikas Upadhyay.
Its last annual general meeting (AGM) was held on 30 August 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at Rainbow Apartment Rz – 433A/1 Third Floor Gali No. 9, Dada Chhatri Wala Marg Raj Nagar Part – 1 Palam Colony, New Delhi, Delhi, India – 110077.
As per the financials filed for FY 2019, the company reported a revenue of ₹3.82 Lakh, a decline of 44% compared to the previous year. For the same year it recorded a net loss of ₹10,237 (net margin -2.7%) and EBITDA of ₹801 (EBITDA margin 0.2%).
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Long Life Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressRainbow Apartment Rz – 433A/1 Third Floor Gali No. 9, Dada Chhatri Wala Marg Raj Nagar Part – 1 Palam Colony, New Delhi, Delhi, India – 110077
- IndustryManufacturing, Other, Manufacturing
To see the full contact details of Long Life Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Long Life Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Long Life Pharmaceuticals Private Limited, buy the company report.
Financials of Long Life Pharmaceuticals Private Limited
FY 2019 filings availableLong Life Pharmaceuticals Private Limited reported revenue of ₹3.82 Lakh (down 44% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue fell 44% in the latest year. EBITDA fell 86% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹801 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹10,237 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 0.2% | |||
| Net Profit Margin | -2.7% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Long Life Pharmaceuticals Private Limited, buy the company report.
Board of directors of Long Life Pharmaceuticals Private Limited
Long Life Pharmaceuticals has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dev Muni Upadhyay | Managing Director | 07 Apr 2017 | 9 Years 7 Months | Current |
| Vikas Upadhyay | Director | 28 Mar 2016 | 10 Years 7 Months | Current |
| Prakash Upadhyay | Director | 04 Mar 2016 | 10 Years 8 Months | Current |
Peer comparison
Long Life Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Long Life Pharmaceuticals Private Limitedthis company | ₹3.82 Lakh (FY 2019) | -₹10,237 | -2.7% | -44.0% | New Delhi, Delhi, India | |
| Athang Formulations Private Limited | ₹3.82 Lakh (FY 2023) | Pune, Maharashtra, India | ||||
| Socium Pharmaceuticals Private Limited | ₹3.8 Lakh (FY 2024) | 234.0% | Delhi, India | |||
| Vidushi Pharmaceuticals Private Limited | ₹3.8 Lakh (FY 2022) | 2135.0% | Ghaziabad, Uttar Pradesh, India |
To see the full peer comparison of Long Life Pharmaceuticals Private Limited, buy the company report.
Auditor
Long Life Pharmaceuticals Private Limited is audited by JOLLY & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JOLLY & CO. | FY 2017 | 012279N |
Shareholding
The shareholding of Long Life Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Long Life Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Long Life Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Long Life Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Long Life Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AADCL0261G1ZR | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Long Life Pharmaceuticals Private Limited, buy the company report.
Recent activity
Long Life Pharmaceuticals Private Limited has 6 board changes on record since 2016: 3 appointments and 3 cessations. The latest: Ajay Kumar Mishra ceased to be Additional Director on 30 Jun 2025.
Frequently asked questions
Long Life Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in other, within the manufacturing industry. It was incorporated on 04 March 2016 (10+ years old) and is registered under CIN U36990DL2016PTC292179.
Long Life Pharmaceuticals has 3 current directors:
- Dev Muni Upadhyay - Managing Director
- Vikas Upadhyay - Director
- Prakash Upadhyay - Director
The latest financial statements of Long Life Pharmaceuticals on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 August 2019. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Long Life Pharmaceuticals is 09AADCL0261G1ZR, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Long Life Pharmaceuticals is U36990DL2016PTC292179. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Long Life Pharmaceuticals was incorporated on 04 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Long Life Pharmaceuticals by revenue are Athang Formulations Private Limited, Socium Pharmaceuticals Private Limited, Vidushi Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (retail trading).
Ajay Kumar Mishra ceased to be Additional Director on 30 Jun 2025. Vikas Upadhyay ceased to be Additional Director on 31 Dec 2017. Dev Muni Upadhyay was appointed as Managing Director on 07 Apr 2017. Long Life Pharmaceuticals has 6 board changes on record in total.
The registered office of Long Life Pharmaceuticals is at Rainbow Apartment Rz – 433A1 Third Floor Gali No. 9, Dada Chhatri Wala Marg Raj Nagar Part – 1 Palam Colony, New Delhi, Delhi, India – 110077.
Long Life Pharmaceuticals operates in the manufacturing industry, in the other segment.
The compliance status of Long Life Pharmaceuticals is active non-compliant as of 09 September 2026. The company is actively filing with the Registrar of Companies.

